SCHEMBL10696019

SCHEMBL10696019

CCNC(=O)CNC1C=CC=CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.31
FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10697548 0.84 EPHX2 (0.35) FAAH
SCHEMBL10698592 0.79 KDM1A (0.43) FAAH
SCHEMBL10798431 0.78
SCHEMBL607551 0.78
SCHEMBL27817578 0.77
SCHEMBL1878772 0.77 EPHX2 (0.33)
SCHEMBL14295926 0.77
SCHEMBL1888270 0.76 GAA (0.38)
Hydrochloric Acid SCHEMBL5031179 0.76
SCHEMBL10529046 0.76 KDM1A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0271023-A2 Use of dihydrophenylamino-acid derivatives and medicines containing them for immunomodulation and cytostasis GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-06-15 EP claimed
EP-0271023-A2 Use of dihydrophenylamino-acid derivatives and medicines containing them for immunomodulation and cytostasis GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-06-15 EP disclosed